Carina Wattmo
41 – 50 of 88
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
- Contribution to journal › Article
-
Mark
Risk Factors That Affect Life Expectancy in Alzheimer's Disease: A 15-Year Follow-Up.
- Contribution to journal › Article
-
Mark
Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.
Nägga, Katarina LU ; Wattmo, Carina LU ; Zhang, Yi ; Wahlund, Lars-Olof and Palmqvist, Sebastian LU
(2014)
In Alzheimer's Research & Therapy
6(4).
- Contribution to journal › Article
-
Mark
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
- Contribution to journal › Article
-
Mark
Factors that affect life-span in mild versus moderate Alzheimer’s disease.
(2014) 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 35(Suppl. 1). p.25-25
- Contribution to journal › Published meeting abstract
-
Mark
Early- versus Late-onset Alzheimer’s Disease—3-year Outcomes of Cholinesterase Inhibitor Treatment in Routine Clinical Practice.
(2014) 7th Clinical Trials Conference on Alzheimer’s Disease (CTAD)
- Contribution to conference › Poster
-
Mark
The effect of functional capacity and concomitant medications on life expectancy in Alzheimer’s disease.
(2014) Alzheimer’s Association International Conference (AAIC), 2014
- Contribution to conference › Poster
-
Mark
Prevalence of Lewy body dementia and neuroleptic treatment in nursing homes in Malmö, Sweden.
(2014) Alzheimer’s Association International Conference (AAIC), 2014
- Contribution to conference › Poster
- 2013
-
Mark
A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy
- Contribution to journal › Article
-
Mark
Mild versus Moderate Stage of Alzheimer’s Disease—Three-year Outcomes of Cholinesterase Inhibitor Therapy in a Routine Clinical Setting.
- Contribution to conference › Abstract